Michael Alfieri is CFO at Aldeyra Therapeutics, Inc. (ALDX). They have made 3 open-market trades across 2 companies since 2018, most recently 2026-03-18.
CIK 0001744687
3 open-market purchases totalling $26K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALDX | 7,500 | $5K |
| GNCA | 10,000 | $510 |
| Total | $5K |
Shares reported on the most recent Form 4, priced at the 2026-03-19 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.